Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the CARILLON® Mitral Contour System™, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses a catheter based approach to reshape the mitral valve and reduce mitral regurgitation.
This novel therapy has allowed Cardiac Dimensions, Inc. to emerge as a leader in our field. Our clinical experience of the CARILLON Mitral Contour System includes studies conducted at multiple centers worldwide.
We were founded in 2001 and are based in Kirkland, Washington. Our management team is composed of seasoned industry veterans dedicated to the success of our product and our company. We are a privately owned company backed by leaders in the venture field such as MPM Capital, InterWest Partners, Polaris Venture Partners, Frazier Healthcare Ventures, Lumira Capital and Johnson & Johnson Development Corp.